References
- Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609–630.
- Bouroncle BA. Leukemic reticuloendotheliosis (hairy cell leukemia). Blood. 1979;53(3):412–436.
- Pettirossi V, Santi A, Imperi E, et al. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity. Blood. 2015;125(8):1207–1216.
- Shao H, Calvo KR, Gronborg M, et al. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res. 2013;37(4):401–409.
- Kraut E. Infectious complications in hairy cell leukemia. Leuk Lymphoma. 2011;52(Suppl. 2):50–52.
- Grever MR, Abdel-Wahab O, Andritsos LA, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017;129(5):553–560.
- Matutes E. Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021? Expert Rev Hematol. 2021;14(4):355–363.
- Jansen J, Hermans J. Clinical staging system for hairy-cell leukemia. Blood. 1982;60(3):571–577.
- Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by world health organization subtypes. CA Cancer J Clin. 2016;66(6):443–459.
- HCL. Hairy Cell Leukemia Foundation; 2021, www.hairycellleukemia.org.
- Ohno-Machado L, Agha Z, Bell DS, et al. pSCANNER: patient-centered scalable national network for effectiveness research. J Am Med Inform Assoc. 2014;21(4):621–626.
- Weber GM, Murphy SN, McMurry AJ, et al. The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J Am Med Inform Assoc. 2009;16(5):624–630.
- Jacobson RS, Becich MJ, Bollag RJ, et al. A federated network for translational cancer research using clinical data and biospecimens. Cancer Res. 2015;75(24):5194–5201.
- Mathur P. Design of a scalable and affordable local research registry pipeline [abstract]. AMIA Joint Summits Proceedings; 2016.
- Orphanet, The Portal for Rare Diseases and Orphan Drugs, 2021, https://www.orpha.net/consor/cgi-bin/index.php
- NORD – National Organization for Rare Disorders. Hairy cell leukemia; 2013, https://rarediseases.org.
- Schilsky RL, Michels DL, Kearbey AH, et al. Building a rapid learning health care system for oncology: the regulatory framework of CancerLinQ. J Clin Oncol. 2014;32(22):2373–2379.